PL4041733T3 - Pochodne mające ugrupowanie 2,3-dihydro-1h-indenu lub 2,3-dihydrobenzofuranu lub ich farmaceutycznie dopuszczalne sole oraz kompozycje farmaceutyczne je zawierające - Google Patents
Pochodne mające ugrupowanie 2,3-dihydro-1h-indenu lub 2,3-dihydrobenzofuranu lub ich farmaceutycznie dopuszczalne sole oraz kompozycje farmaceutyczne je zawierająceInfo
- Publication number
- PL4041733T3 PL4041733T3 PL20887669.8T PL20887669T PL4041733T3 PL 4041733 T3 PL4041733 T3 PL 4041733T3 PL 20887669 T PL20887669 T PL 20887669T PL 4041733 T3 PL4041733 T3 PL 4041733T3
- Authority
- PL
- Poland
- Prior art keywords
- indene
- dihydro
- derivatives
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 title 2
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical group C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190146679 | 2019-11-15 | ||
| PCT/KR2020/015864 WO2021096238A1 (en) | 2019-11-15 | 2020-11-12 | Novel derivatives having 2,3-dihydro-1h-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4041733T3 true PL4041733T3 (pl) | 2024-09-23 |
Family
ID=75911374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20887669.8T PL4041733T3 (pl) | 2019-11-15 | 2020-11-12 | Pochodne mające ugrupowanie 2,3-dihydro-1h-indenu lub 2,3-dihydrobenzofuranu lub ich farmaceutycznie dopuszczalne sole oraz kompozycje farmaceutyczne je zawierające |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230002379A1 (pl) |
| EP (2) | EP4389744A1 (pl) |
| JP (1) | JP2023503830A (pl) |
| KR (1) | KR20210059632A (pl) |
| CN (1) | CN114829361B (pl) |
| AU (1) | AU2020384066A1 (pl) |
| BR (1) | BR112022009409A2 (pl) |
| CA (1) | CA3154313A1 (pl) |
| ES (1) | ES2984255T3 (pl) |
| MX (1) | MX2022005679A (pl) |
| PL (1) | PL4041733T3 (pl) |
| RS (1) | RS65662B1 (pl) |
| WO (1) | WO2021096238A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7065951B2 (ja) | 2017-09-22 | 2022-05-12 | ジュビラント エピパッド エルエルシー | Ｐａｄ阻害剤としての複素環式化合物 |
| ES2941512T3 (es) | 2017-10-18 | 2023-05-23 | Jubilant Epipad LLC | Compuestos de imidazo-piridina como inhibidores de PAD |
| CA3080677A1 (en) | 2017-11-06 | 2019-05-09 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
| PL3704120T3 (pl) | 2017-11-24 | 2024-09-16 | Jubilant Episcribe Llc | Związki heterocykliczne jako inhibitory prmt5 |
| CN112105610B (zh) | 2018-03-13 | 2024-01-26 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物 |
| JP2024529298A (ja) | 2021-07-09 | 2024-08-06 | プレキシウム インコーポレイテッド | Ｉｋｚｆ２を調節するアリール化合物及び医薬組成物 |
| WO2024090917A1 (en) * | 2022-10-24 | 2024-05-02 | Yuhan Corporation | Novel salt of dimethyl-2,3-dihydro-1h-indene derivative and processes for preparing the same |
| WO2024090919A1 (en) * | 2022-10-24 | 2024-05-02 | Yuhan Corporation | Improved processes for preparing dimethyl-2,3-dihydro-1h-indene derivatives |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9600683D0 (sv) * | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| GB0400812D0 (en) | 2004-01-14 | 2004-02-18 | Celltech R&D Ltd | Novel compounds |
| EP1811991B1 (en) | 2004-11-10 | 2018-11-07 | Genzyme Corporation | Treatment of type 2 diabetes using inhibitors of glycosphingolipid synthesis |
| EP2594564B1 (en) | 2007-05-31 | 2016-09-28 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| WO2009117150A2 (en) | 2008-03-20 | 2009-09-24 | Genzyme Corporation | Method of treating lupus with ceramide derivatives |
| JP2011529500A (ja) | 2008-07-28 | 2011-12-08 | ジェンザイム コーポレーション | 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害 |
| WO2010091104A1 (en) * | 2009-02-06 | 2010-08-12 | Exelixis, Inc. | Glucosylceramide synthase inhibitors |
| WO2010091164A1 (en) * | 2009-02-06 | 2010-08-12 | Exelixis, Inc. | Inhibitors of glucosylceramide synthase |
| PL2685986T3 (pl) * | 2011-03-18 | 2020-07-27 | Genzyme Corporation | Inhibitor syntazy glukozyloceramidowej |
| WO2013059119A1 (en) * | 2011-10-17 | 2013-04-25 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| MA37975B2 (fr) * | 2012-09-11 | 2021-03-31 | Genzyme Corp | Inhibiteurs de synthase de glucosylcéramide |
| CN105745206B (zh) * | 2013-09-20 | 2019-08-13 | 生物马林药物股份有限公司 | 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂 |
| WO2019079626A1 (en) * | 2017-10-19 | 2019-04-25 | Samumed, Llc | 6- (HETEROARYL 5-CHAIN) ISOQUINOLIN-3-YL CARBOXAMIDES, THEIR PREPARATION AND THEIR USE |
-
2020
- 2020-11-12 PL PL20887669.8T patent/PL4041733T3/pl unknown
- 2020-11-12 AU AU2020384066A patent/AU2020384066A1/en active Pending
- 2020-11-12 JP JP2022527911A patent/JP2023503830A/ja active Pending
- 2020-11-12 US US17/755,843 patent/US20230002379A1/en active Pending
- 2020-11-12 KR KR1020200150785A patent/KR20210059632A/ko unknown
- 2020-11-12 CA CA3154313A patent/CA3154313A1/en active Pending
- 2020-11-12 EP EP24163536.6A patent/EP4389744A1/en active Pending
- 2020-11-12 EP EP20887669.8A patent/EP4041733B1/en active Active
- 2020-11-12 ES ES20887669T patent/ES2984255T3/es active Active
- 2020-11-12 CN CN202080075084.9A patent/CN114829361B/zh active Active
- 2020-11-12 RS RS20240700A patent/RS65662B1/sr unknown
- 2020-11-12 BR BR112022009409A patent/BR112022009409A2/pt unknown
- 2020-11-12 WO PCT/KR2020/015864 patent/WO2021096238A1/en active Application Filing
- 2020-11-12 MX MX2022005679A patent/MX2022005679A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114829361A (zh) | 2022-07-29 |
| ES2984255T3 (es) | 2024-10-29 |
| EP4041733A4 (en) | 2023-08-30 |
| CN114829361B (zh) | 2024-07-16 |
| AU2020384066A1 (en) | 2022-04-21 |
| US20230002379A1 (en) | 2023-01-05 |
| EP4041733B1 (en) | 2024-05-08 |
| JP2023503830A (ja) | 2023-02-01 |
| CA3154313A1 (en) | 2021-05-20 |
| EP4041733A1 (en) | 2022-08-17 |
| MX2022005679A (es) | 2022-06-27 |
| KR20210059632A (ko) | 2021-05-25 |
| WO2021096238A1 (en) | 2021-05-20 |
| EP4389744A1 (en) | 2024-06-26 |
| EP4041733C0 (en) | 2024-05-08 |
| RS65662B1 (sr) | 2024-07-31 |
| BR112022009409A2 (pt) | 2022-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS65662B1 (sr) | Derivati koji imaju 2,3-dihidro-1h-inden ili 2,3-dihidrobenzofuranski deo ili njihovu farmaceutski prihvatljivu so i farmaceutske kompozicije koje ih sadrže | |
| EP4041734C0 (en) | DERIVATIVES CONTAINING 1,2,3,4-TETRAHYDRONAPHTHALENE UNIT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| IL283539A (en) | 3,3-difluoroallylamines or their salts and pharmaceutical preparations containing them | |
| WO2016064082A3 (ko) | 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도 | |
| EP3481831A4 (en) | NOVEL 4-AMINOPYRAZOLO [3,4-D] PYRIMIDINYLAZABICYCLO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| WO2019165043A3 (en) | Indane-amines as pd-l1 antagonists | |
| IL289932A (en) | History of 6,3-diamino-pyridazin-3-yl, pharmaceutical preparations containing them and their use as pro-apoptotic agents | |
| PT3759083T (pt) | Derivados de 2,4-diaminoquinazolina e seus usos no tratamento de infeções por vírus, cancro ou alergias | |
| EP3768675A4 (en) | NEW TRIAZOLONE DERIVATIVES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EP3894408A4 (en) | TRIAZOLOPYRIDIN-3-ONE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EP4339192A3 (en) | Compounds and compositions for the treatment of cancer | |
| EP3620457A4 (en) | COMPOUND DERIVED FROM PYRIMIDINE, OPTICAL ISOMER, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING A TYRO 3-RELATED DISEASE, CONSIDERING IT AS AN ACTIVE INGREDIENT | |
| WO2019194773A3 (en) | The combination comprising linagliptin and metformin | |
| EP3539978A4 (en) | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT | |
| WO2020009675A3 (en) | Solid oral pharmaceutical compositions of linagliptin | |
| WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof | |
| WO2016006975A3 (en) | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof | |
| MX2021010022A (es) | Composicion farmaceutica. | |
| IL282999A (en) | 4,3,1-oxadiazolone compound and drug | |
| PL3781263T3 (pl) | Farmaceutycznie skuteczne związki selektywnie hamujące izoformy miozyny 2 | |
| WO2019098572A3 (ko) | 간염 바이러스에 의해 유발된 간 섬유화의 개선을 위한 약학 조성물 | |
| WO2020018053A3 (en) | The tablet comprising dasatinib | |
| WO2019151965A3 (en) | Solid oral pharmaceutical compositions comprising apixaban | |
| EP3814340A4 (en) | NOVEL CATECHOLD DERIVATIVES OR THEIR SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| WO2019209217A3 (en) | Modified release formulations of flurbiprofen |